Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
V Atger, … , N Moatti, G Rothblat
V Atger, … , N Moatti, G Rothblat
Published December 1, 1995
Citation Information: J Clin Invest. 1995;96(6):2613-2622. https://doi.org/10.1172/JCI118326.
View: Text | PDF
Research Article Article has an altmetric score of 3

Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

  • Text
  • PDF
Abstract

The ability of whole serum to promote cell cholesterol efflux and the relationships between apoprotein and lipoprotein components of human serum efflux have been investigated previously (de la Llera Moya, M., V. Atger, J.L. Paul, N. Fournier, N. Moatti, P. Giral, K.E. Friday, and G.H. Rothblat. 1994. Arterioscler. Thromb. 14:1056-1065). We have now used this experimental system to study the selective effects of two human lipoprotein-related proteins, apoprotein AI (apo AI) and cholesteryl ester transfer protein (CETP) on cell cholesterol efflux, when these proteins are expressed in transgenic mice. The percent efflux values for cholesterol released in 4 h from Fu5AH donor cells to 5% sera from the different groups of mice were in the order: background = human apo AI transgenic (HuAITg) > human CETP transgenic (HuCETPTg) > human apo AI and CETP transgenic (HuAICETPTg) >> apo AI knockout mice. In each group of mice a strong, positive correlation (r2 ranging from 0.64 to 0.76) was found between efflux and HDL cholesterol concentrations. The slopes of these regression lines differed between groups of mice, indicating that the cholesterol acceptor efficiencies of the sera differed among groups. These differences in relative efficiencies can explain why cholesterol efflux was not proportional to the different HDL levels in the various groups of mice. We can conclude that: (a) HDL particles from HuAITg mice are less efficient as cholesterol acceptors than HDL from the background mice; (b) despite a lower average efflux due to lower HDL cholesterol concentrations, HDL particles are more efficient in the HuCETPTg mice than in the background mice; and (c) the coexpression of both human apo AI and CETP improves the efficiency of HDL particles in the HuAICETPTg mice when compared with the HuAITg mice. We also demonstrated that the esterification of the free cholesterol released from the cells by lecithin cholesterol acyltransferase in the serum was reduced in the HuAITg and AI knockout mice, whereas it was not different from background values in the two groups of mice expressing human CETP.

Authors

V Atger, M de la Llera Moya, M Bamberger, O Francone, P Cosgrove, A Tall, A Walsh, N Moatti, G Rothblat

×

Total citations by year

Year: 2021 2018 2016 2014 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 Total
Citations: 1 1 1 4 3 1 1 1 1 2 5 3 6 5 2 37
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (37)

Title and authors Publication Year
Human cholesteryl ester transport protein transgene promotes macrophage reverse cholesterol transport in C57BL/6 mice and phospholipid transfer protein gene knockout mice
N Liu, Y Si, Y Zhang, S Guo, S Qin
Journal of Physiology and Biochemistry 2021
A critical appraisal of the measurement of serum ‘cholesterol efflux capacity’ and its use as surrogate marker of risk of cardiovascular disease
M Anastasius, C Luquain-Costaz, M Kockx, W Jessup, L Kritharides
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2018
Clinically used selective estrogen receptor modulators affect different steps of macrophage-specific reverse cholesterol transport
ME Fernández-Suárez, JC Escolà-Gil, O Pastor, A Dávalos, F Blanco-Vaca, MA Lasunción, J Martínez-Botas, D Gómez-Coronado
Scientific Reports 2016
Targeting adipose tissue via systemic gene therapy
SM O'Neill, C Hinkle, SJ Chen, A Sandhu, R Hovhannisyan, S Stephan, WR Lagor, RS Ahima, JC Johnston, MP Reilly
Gene Therapy 2014
HDL-targeted therapies: progress, failures and future
BA Kingwell, MJ Chapman, A Kontush, NE Miller
Nature Reviews Drug Discovery 2014
Humans With Atherosclerosis Have Impaired ABCA1 Cholesterol Efflux and Enhanced High-Density Lipoprotein Oxidation by Myeloperoxidase
B Shao, C Tang, A Sinha, PS Mayer, GD Davenport, N Brot, MN Oda, XQ Zhao, JW Heinecke
Circulation research 2014
Macrophage-Independent Regulation of Reverse Cholesterol Transport by Liver X Receptors
SR Breevoort, J Angdisen, IG Schulman
Arteriosclerosis, thrombosis, and vascular biology 2014
Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice
DT Valenta, JJ Bulgrien, CL Banka, LK Curtiss
Atherosclerosis 2006
Endothelial lipase: Its role in cardiovascular disease
ME Paradis, B Lamarche
Canadian Journal of Cardiology 2006
Endothelial lipase: its role in cardiovascular disease
ME Paradis, B Lamarche
The Canadian journal of cardiology 2006
Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes
D Masson, JP de Barros, Z Zak, T Gautier, NL Guern, M Assem, JW Chisholm, JR Paterniti, L Lagrost
Journal of lipid research 2005
Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1
JW Beulens, A Sierksma, A Tol, N Fournier, T Gent, JL Paul, HF Hendriks
Journal of lipid research 2004
Low High-Density Lipoprotein Cholesterol: Physiological Background, Clinical Importance and Drug Treatment
M Hersberger, A von Eckardstein
Drugs 2003
Mast Cell Chymase Degrades ApoE and ApoA-II in ApoA-I–Knockout Mouse Plasma and Reduces Its Ability to Promote Cellular Cholesterol Efflux
M Lee, L Calabresi, G Chiesa, G Franceschini, PT Kovanen
Arteriosclerosis, thrombosis, and vascular biology 2002
Arg123-Tyr166 domain of human ApoA-I is critical for HDL-mediated inhibition of macrophage homing and early atherosclerosis in mice
P Holvoet, K Peeters, S Lund-Katz, A Mertens, P Verhamme, R Quarck, D Stengel, M Lox, E Deridder, H Bernar, M Nickel, G Theilmeier, E Ninio, MC Phillips
Arteriosclerosis, thrombosis, and vascular biology 2001
High Density Lipoproteins and Arteriosclerosis: Role of Cholesterol Efflux and Reverse Cholesterol Transport
A von Eckardstein, JR Nofer, G Assmann
Arteriosclerosis, thrombosis, and vascular biology 2001
Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia
S Yamashita, T Maruyama, K Hirano, N Sakai, N Nakajima, Y Matsuzawa
Atherosclerosis 2000
Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein
S Yamashita
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2000
High-density lipoproteins from human alcoholics exhibit impaired reverse cholesterol transport function
MN Rao, QH Liu, P Marmillot, LB Seeff, DB Strader, MR Lakshman
Metabolism 2000
High Density Lipoprotein Phospholipid Composition Is a Major Determinant of the Bi-directional Flux and Net Movement of Cellular Free Cholesterol Mediated by Scavenger Receptor BI
PG Yancey, M la Llera-Moya, S Swarnakar, P Monzo, SM Klein, MA Connelly, WJ Johnson, DL Williams, GH Rothblat
The Journal of biological chemistry 2000
Human ApoA-IV Overexpression in Transgenic Mice Induces cAMP-Stimulated Cholesterol Efflux From J774 Macrophages to Whole Serum
N Fournier, V Atger, JL Paul, M Sturm, N Duverger, GH Rothblat, N Moatti
Arteriosclerosis, thrombosis, and vascular biology 2000
Remodelling of high density lipoproteins by plasma factors
KA Rye, MA Clay, PJ Barter
Atherosclerosis 1999
Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes
N Fournier, V Atger, JL Paul, ML la Moya, G Rothblat, N Moatti
Atherosclerosis 1999
Increased Cholesterol Efflux Potential of Sera From ApoA-I Milano Carriers and Transgenic Mice
G Franceschini, L Calabresi, G Chiesa, C Parolini, CR Sirtori, M Canavesi, F Bernini
Arteriosclerosis, thrombosis, and vascular biology 1999
Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice
P Holvoet, S Danloy, E Deridder, M Lox, H Bernar, A Dhoest, D Collen
Journal of Clinical Investigation 1998
Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man
T Radeau, M Robb, P Lau, J Borthwick, R McPherson
Atherosclerosis 1998
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow
Annual Review of Nutrition 1998
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
M Dammerman, LA Sandkuijl, JL Halaas, W Chung, JL Breslow
Annual Review of Nutrition 1998
Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice
G Chiesa, C Parolini, M Canavesi, N Colombo, C R Sirtori, R Fumagalli, G Franceschini, F Bernini
Arteriosclerosis, thrombosis, and vascular biology 1998
Sterol Regulatory Element Binding Protein-1 Activates the Cholesteryl Ester Transfer Protein Gene in Vivo but Is Not Required for Sterol Up-regulation of Gene Expression
RA Chouinard, Y Luo, TF Osborne, A Walsh, AR Tall
The Journal of biological chemistry 1998
Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells
VM Atger, ML la Moya, GW Stoudt, WV Rodrigueza, MC Phillips, GH Rothblat
Journal of Clinical Investigation 1997
Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice
O Stein, Y Dabach, G Hollander, M Ben-Naim, G Halperin, JL Breslow, Y Stein
Proceedings of the National Academy of Sciences 1997
The Role of Cholesteryl Ester Transfer Protein and Phospholipid Transfer Protein in the Remodeling of Plasma High-Density Lipoproteins
L Lagrost
Trends in Cardiovascular Medicine 1997
HDL Phospholipid Content and Composition as a Major Factor Determining Cholesterol Efflux Capacity From Fu5AH Cells to Human Serum
N Fournier, JL Paul, V Atger, A Cogny, T Soni, M de la Llera-Moya, G Rothblat, N Moatti
Arteriosclerosis, thrombosis, and vascular biology 1997
CETP and exchangeable apoproteins: common features in lipid binding activity
V M Bolaños-García, M Soriano-García, J Mas-Oliva
Molecular and Cellular Biochemistry 1997
Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes
OL Francone, L Royer, M Haghpassand
Journal of lipid research 1996
Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats
N Fournier, M de la Llera Moya, BF Burkey, JB Swaney, J Paterniti, N Moatti, V Atger, GH Rothblat
Journal of lipid research 1996

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
15 readers on Mendeley
See more details